Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain ...Middle East

SAN DIEGO, Jan. 7, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it has entered into a five-year distributor partnership with CrossLink Life Sciences, LLC to expand the sales network supporting ZYNRELEF®...

Hence then, the article about heron therapeutics announces partnership with crosslink life sciences to expand promotional effort for zynrelef the first and only non opioid dual acting local anesthetic for post operative pain was published today ( Monday 08/01/2024 - 01:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain )

Also on site :

• Instructure strikes deal with hackers who breached it twice .. TechCrunch
• AI voice startup Vapi hits $500M valuation after winning Amazon Ring over 40 rivals
• SAP CEO: the AI race is being fought in the wrong place